End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
130.2 ZAR | +1.67% | -17.06% | -29.72% |
04-23 | EMEA Morning Briefing : Shares Set to Rise as Geopolitical Concerns Ease | DJ |
04-17 | South Africa's PetroSA targets Mozambique gas in new sales deal | RE |
Summary
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Its low valuation, with P/E ratio at 3.25 and 2.54 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.62 for the 2024 fiscal year.
- The company appears to be poorly valued given its net asset value.
- This company will be of major interest to investors in search of a high dividend stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-29.72% | 4.4B | B+ | ||
-0.19% | 74.89B | B | ||
+0.09% | 46.52B | A- | ||
-4.19% | 30.82B | C | ||
+10.27% | 18.19B | B | ||
-10.05% | 11.54B | B | ||
+6.39% | 11.24B | A- | ||
-8.09% | 9.73B | - | ||
+2.79% | 9.4B | A- | ||
+5.73% | 9.37B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SOL Stock
- Ratings Sasol Limited